Abstract
Predictive QSAR models for the inhibition activities of nitrogen-containing bisphosphonates (N-BPs) against farnesyl pyrophosphate synthase (FPPS) from Leishmania major (LeFPPS) were developed using a data set of 97 compounds. The QSAR models were developed through the use of Artificial Neural Networks and Random Forest learning procedures. The predictive ability of the models was tested by means of leave-one-out cross-validation; Q2values ranging from 0.45-0.79 were obtained for the regression models. The consensus prediction for the external evaluation set afforded high predictive power (Q2=0.76 for 35 compounds).
The robustness of the QSAR models was also evaluated using a Y-randomization procedure. A small set of 6 new N-BPs were designed and synthesized applying the Michael reaction of tetrakis (trimethylsilyl) ethenylidene bisphosphonate with amines. The inhibition activities of these compounds against LeFPPS were predicted by the developed QSAR models and were found to correlate with their fungistatic activities against Candida albicans. The antifungal activities of N-BPs bearing n-butyl and cyclopropyl side chains exceeded the activities of Fluconazole, a triazole-containing antifungal drug. In conclusion, the N-BPs developed here present promising candidate drugs for the treatment of fungal diseases.
Keywords: Artificial neural networks, drug design, fungistatic activity, Michael addition, nitrogen-containing bisphosphonates, QSAR.
Current Drug Discovery Technologies
Title:Design and Synthesis of New Potent Inhibitors of Farnesyl Pyrophosphate Synthase
Volume: 11 Issue: 2
Author(s): Volodymyr Prokopenko, Vasyl Kovalishyn, Michael Shevchuk, Iryna Kopernyk, Larysa Metelytsia, Vadim Romanenko, Sergey Mogilevich and Valery Kukhar
Affiliation:
Keywords: Artificial neural networks, drug design, fungistatic activity, Michael addition, nitrogen-containing bisphosphonates, QSAR.
Abstract: Predictive QSAR models for the inhibition activities of nitrogen-containing bisphosphonates (N-BPs) against farnesyl pyrophosphate synthase (FPPS) from Leishmania major (LeFPPS) were developed using a data set of 97 compounds. The QSAR models were developed through the use of Artificial Neural Networks and Random Forest learning procedures. The predictive ability of the models was tested by means of leave-one-out cross-validation; Q2values ranging from 0.45-0.79 were obtained for the regression models. The consensus prediction for the external evaluation set afforded high predictive power (Q2=0.76 for 35 compounds).
The robustness of the QSAR models was also evaluated using a Y-randomization procedure. A small set of 6 new N-BPs were designed and synthesized applying the Michael reaction of tetrakis (trimethylsilyl) ethenylidene bisphosphonate with amines. The inhibition activities of these compounds against LeFPPS were predicted by the developed QSAR models and were found to correlate with their fungistatic activities against Candida albicans. The antifungal activities of N-BPs bearing n-butyl and cyclopropyl side chains exceeded the activities of Fluconazole, a triazole-containing antifungal drug. In conclusion, the N-BPs developed here present promising candidate drugs for the treatment of fungal diseases.
Export Options
About this article
Cite this article as:
Prokopenko Volodymyr, Kovalishyn Vasyl, Shevchuk Michael, Kopernyk Iryna, Metelytsia Larysa, Romanenko Vadim, Mogilevich Sergey and Kukhar Valery, Design and Synthesis of New Potent Inhibitors of Farnesyl Pyrophosphate Synthase, Current Drug Discovery Technologies 2014; 11 (2) . https://dx.doi.org/10.2174/15701638113106660041
DOI https://dx.doi.org/10.2174/15701638113106660041 |
Print ISSN 1570-1638 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6220 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Discovery of New Biomarkers of Cancer Using Proteomics Technology
Current Cancer Therapy Reviews Meet Our Editorial Board Member
Drug Delivery Letters DD-Ligases as a Potential Target for Antibiotics: Past, Present and Future
Current Medicinal Chemistry Optical Techniques in the Assessment of Peripheral Arterial Disease
Current Vascular Pharmacology Perspectives of New Therapies for Endometriosis
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Paclitaxel Loaded Nanoliposomes in Thermosensitive Hydrogel: A Dual Approach for Sustained and Localized Delivery
Anti-Cancer Agents in Medicinal Chemistry Effects of Estrogens on Atherogenesis
Current Vascular Pharmacology Current Management of In Situ and Invasive Cervical Adenocarcinoma
Current Women`s Health Reviews Bupropion in the Depression-Related Sexual Dysfunction: A Systematic Review
CNS & Neurological Disorders - Drug Targets Hormone Replacement Therapy and Stroke
Current Vascular Pharmacology Cubosomes: Innovative Nanostructures for Drug Delivery
Current Drug Delivery Human Chorionic Gonadotropin: A Model Molecule For Oligopeptide-Based Drug Discovery
Endocrine, Metabolic & Immune Disorders - Drug Targets Mucosal Vaccine Vectors: Replication-Competent Versus Replication-Deficient Poxviruses
Current Pharmaceutical Design Mucoadhesive Polymeric Platform for Drug Delivery; A Comprehensive Review
Current Drug Delivery Management of Ovarian Cancer In Younger Women
Reviews on Recent Clinical Trials Use of Peripheral Blood Stem Cells in Tissue Engineering
Current Tissue Engineering (Discontinued) Hot Melt Extrusion and its Application in 3D Printing of Pharmaceuticals
Current Drug Delivery Stem Cell Function, Self-Renewal, Heterogeneity, and Regenerative Potential in Skeletal Muscle Stem Cells
Recent Patents on Regenerative Medicine Preclinical Evaluation of a Zinc Finger Inhibitor Targeting Lentivirus Nucleocapsid Protein in SIV-Infected Monkeys
Current HIV Research Nanotechnologies for Anti-Inflammatory RNAi-Based Gene Silencing Strategies
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry